A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Prosthetic heart valve thrombosis as a source of coronary embolism: a novel strategy in the management of acute coronary syndrome (the Troia-core trial)
2013
European Heart Journal
Conclusions: This meta-analysis did not show any differences in long-term mortality rates, thromboembolic events, or hemorrhage between BP and MP patients after 20 years of follow-up. However, MP was associated with lower risks of all other outcomes, except paravalvular leak. P2133 | BEDSIDE Prosthetic heart valve thrombosis as a source of coronary embolism: a novel strategy in the management of acute coronary syndrome (the Troia-core trial)
doi:10.1093/eurheartj/eht308.p2133
fatcat:qubecdetynhjlgggn6bwqktfne